[HTML][HTML] Revisiting metallodrugs for the treatment of skin cancers
CM Manzano, DH Nakahata, REF de Paiva - Coordination Chemistry …, 2022 - Elsevier
Metallodrugs were classically screened against skin cancer (either in vitro or in vivo) at the
peak of the development of platinum anticancer agents. New systematic studies appeared in …
peak of the development of platinum anticancer agents. New systematic studies appeared in …
Therapeutic potential of the phosphino Cu (I) complex (HydroCuP) in the treatment of solid tumors
V Gandin, C Ceresa, G Esposito, S Indraccolo… - Scientific reports, 2017 - nature.com
Abstract [Cu (thp) 4][PF6](HydroCuP) is a phosphino copper (I) complex highly soluble and
stable in physiological media that has been developed as a possible viable alternative to …
stable in physiological media that has been developed as a possible viable alternative to …
New NNN pincer copper complexes as potential anti-prostate cancer agents
JJ Qu, P Bai, WN Liu, ZL Liu, JF Gong, JX Wang… - European Journal of …, 2022 - Elsevier
Abstract Eleven novel NNN Cu (II) complexes supported by a tridentate bis (imidazo [1, 2-α]
pyridin-2-yl) pyridine ligand were synthesized and characterized by elemental analysis …
pyridin-2-yl) pyridine ligand were synthesized and characterized by elemental analysis …
Highly hydrophilic gold nanoparticles as carrier for anticancer copper (I) complexes: Loading and release studies for biomedical applications
I Fratoddi, I Venditti, C Battocchio, L Carlini, S Amatori… - Nanomaterials, 2019 - mdpi.com
Gold nanoparticles (AuNPs), which are strongly hydrophilic and dimensionally suitable for
drug delivery, were used in loading and release studies of two different copper (I)-based …
drug delivery, were used in loading and release studies of two different copper (I)-based …
Heteroleptic copper (I) complexes of “scorpionate” bis-pyrazolyl carboxylate ligand with auxiliary phosphine as potential anticancer agents: An insight into cytotoxic …
New copper (I) complexes [CuCl (PPh3)(L)](1: L= LA= 4-carboxyphenyl) bis (3, 5-
dimethylpyrazolyl) methane;(2: L= LB= 3-carboxyphenyl) bis (3, 5-dimethylpyrazolyl) …
dimethylpyrazolyl) methane;(2: L= LB= 3-carboxyphenyl) bis (3, 5-dimethylpyrazolyl) …
Synthesis and cytotoxicity studies of Cu (I) and Ag (I) complexes based on sterically hindered β-diketonates with different degrees of fluorination
Design, synthesis, and in vitro antitumor properties of Cu (I) and Ag (I) phosphane
complexes supported by the anions of sterically hindered β-diketone ligands, 1, 3 …
complexes supported by the anions of sterically hindered β-diketone ligands, 1, 3 …
Copper electroactivity in Prussian blue-based cathode disclosed by operando XAS
The electronic and structural evolution of copper hexacyanoferrate (CuHCF) cathode
material was studied by operando X-ray absorption spectroscopy (XAS) simultaneously at …
material was studied by operando X-ray absorption spectroscopy (XAS) simultaneously at …
Direct label-free imaging of brain tissue using synchrotron light: a review of new spectroscopic tools for the modern neuroscientist
The incidence of brain disease and brain disorders is increasing on a global scale.
Unfortunately, development of new therapeutic strategies has not increased at the same …
Unfortunately, development of new therapeutic strategies has not increased at the same …
Antiproliferative Homoleptic and heteroleptic phosphino silver (I) complexes: Effect of ligand combination on their biological mechanism of action
K Dammak, M Porchia, M De Franco, M Zancato… - Molecules, 2020 - mdpi.com
A series of neutral mixed-ligand [HB (pz) 3] Ag (PR3) silver (I) complexes (PR3= tertiary
phosphine,[HB (pz) 3]−= tris (pyrazolyl) borate anion), and the corresponding homoleptic [Ag …
phosphine,[HB (pz) 3]−= tris (pyrazolyl) borate anion), and the corresponding homoleptic [Ag …
Cu (I) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of …
D Sequeira, PV Baptista, R Valente… - Dalton …, 2021 - pubs.rsc.org
Cancer is one of the worst health issues worldwide, representing the second leading cause
of death. Current chemotherapeutic drugs face some challenges like the acquired resistance …
of death. Current chemotherapeutic drugs face some challenges like the acquired resistance …